Owlstone Medical has developed and commercialized Breath Biopsy® Products and Services for the reliable collection and analysis of volatile organic compound (VOC) biomarkers on breath. We lead the world’s largest breath based clinical trials and have established the first high volume breath analysis lab with ISO 9001 certification and a rigorous system of quality checks at every stage of the workflow. Our Breath Biopsy OMNI service for pharmaceutical and academic customers is our complete solution for global VOC biomarker discovery with high-confidence biomarker identification and validation to support drug and diagnostics development programs. We are also experts in miniaturized VOC detection technologies based on Field-Asymmetric Ion Mobility Spectrometry (FAIMS). Once suitable clinical biomarkers have been identified, we have capabilities to devise cost effective, rapid, small footprint devices for point of care, near patient or even home-based testing. Unlike liquid and tissue biopsies, which require blood or tissue samples to be taken, Breath Biopsy provides a completely non-invasive solution that maximizes patient comfort for biomarker measurement.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.